Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB288394

Endosialin/CD248/TEM1 Antibody (OTI4B8), PE, Novus Biologicals™
SDP

Catalog No. NB288394 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB288394 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB288394 Supplier Novus Biologicals Supplier No. NBP272075PE
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Endosialin/CD248/TEM1 Monoclonal antibody specifically detects Endosialin/CD248/TEM1 in Human samples. It is validated for Western Blot

Specifications

Antigen Endosialin/CD248/TEM1
Applications Western Blot
Classification Monoclonal
Clone OTI4B8
Conjugate PE
Dilution Western Blot
Formulation PBS
Gene Alias 2610111G01Rik, CD164 sialomucin-like 1, CD164L1, CD248 antigen, CD248 antigen, endosialin, CD248 molecule, endosialin, endosialin, MGC119479, TEM1MGC119478, Tumor endothelial marker 1
Host Species Mouse
Immunogen Human recombinant protein fragment corresponding to amino acids 20-300 of human CD248(NP_065137) produced in E.coli.
Purification Method Immunogen affinity purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Cancer
Primary or Secondary Primary
Gene ID (Entrez) 57124
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG2b
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.